North America Nuclear Imaging Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Nuclear Imaging Devices Market Segmentation, By Technology (Positron Emission Tomography, Single Photon Emission Computed Tomography, and Planar Scintigraphy), Application (Oncology, Cardiology, Neurology, and Others), End-User (Hospitals, Diagnostic Imaging Centers, and Others) - Industry Trends and Forecast to 2032

Nuclear Imaging Devices Market Size

• The North America nuclear imaging devices market size was valued at USD 3.24 billion in 2024 and is expected to reach USD 6.06 billion by 2032, at a CAGR of 8.00% during the forecast period
• This growth is driven by factors such as the increasing prevalence of chronic diseases, technological advancements in imaging modalities, and the growing adoption of personalized medicine

Nuclear Imaging Devices Market Analysis

• Nuclear imaging devices are medical imaging equipment that use radioactive materials to diagnose the severity of disorders such as cardiovascular disease, cancer, gastrointestinal, endocrine, neurological, and other brain problems
• These non-invasive devices offer operational data at the molecular and cellular levels, allowing doctors to diagnose and assess medical issues
• U.S. is expected to dominate the nuclear imaging devices market with 34.3% due to its advanced healthcare infrastructure, high healthcare expenditure, and a substantial patient base requiring diagnostic imaging
• Canada is expected to be the fastest growing region in the nuclear imaging devices market during the forecast period due to increasing healthcare investments and technological advancements
• The single photon emission computed tomography (SPECT) segment is expected to dominate the market with a market share with 57.2% due to cost-effectiveness associated with SPECT equipment and procedures

Report Scope and Nuclear Imaging Devices Market Segmentation   

Nuclear Imaging Devices Market Trends

“Shift Toward Hybrid Imaging Modalities”

• Hybrid imaging systems such as PET/CT and SPECT/CT are gaining traction due to their ability to provide both functional and anatomical information, enhancing diagnostic accuracy
• Innovations such as time-of-flight (TOF) PET scanners are improving image quality and reducing scan times, making procedures more efficient and patient-friendly
• Hospitals and diagnostic centers are increasingly adopting these advanced systems to offer comprehensive diagnostic services, particularly in oncology and cardiology
• The adoption of hybrid imaging is expected to drive market growth, with the North American nuclear imaging equipment market

Nuclear Imaging Devices Market Dynamics

Driver

“Rising Incidence of Chronic Diseases”

• With an aging population, the incidence of heart diseases is rising, increasing the demand for diagnostic imaging
• Conditions such as Alzheimer's and Parkinson's are becoming more prevalent, necessitating advanced imaging techniques for early detection and management
•  The increasing burden of these diseases is driving the need for advanced diagnostic tools, including nuclear imaging devices

Opportunity

“Expansion of Personalized Medicine”

• Nuclear imaging allows for the assessment of individual metabolic activity, aiding in the development of personalized treatment plans
• PET scans are particularly useful in identifying specific cancer types and determining the most effective therapies
• Nuclear imaging helps in assessing heart function and planning personalized interventions for cardiovascular patients
• As personalized medicine becomes more prevalent, the demand for nuclear imaging devices is expected to rise, presenting significant growth opportunities in the market

Restraint/Challenge

“High Cost and Reimbursement Issues”

• The initial investment for nuclear imaging systems such as PET/CT and SPECT/CT is substantial, which can be a barrier for smaller healthcare facilities
• Maintaining and operating these advanced systems requires specialized personnel and ongoing maintenance, adding to the overall expenses
• Inconsistent reimbursement rates across different regions and insurance providers can affect the affordability and accessibility of nuclear imaging services
• Economic downturns and budget constraints in healthcare systems can lead to delayed adoption and limited access to advanced imaging technologies
• These financial challenges may hinder the widespread adoption of nuclear imaging devices, potentially affecting market growth

Nuclear Imaging Devices Market Scope

The market is segmented on the basis of technique, application, and end-user.

In 2025, the single photon emission computed tomography (SPECT) is projected to dominate the market with a largest share in technique segment

The single photon emission computed tomography (SPECT) segment is expected to dominate the Nuclear Imaging Devices market with the largest share with 57.2% in 2025 due to cost-effectiveness associated with SPECT equipment and procedures. This affordability extends the adoption of SPECT technology to a wider array of healthcare facilities, including smaller clinics and hospitals with limited resources

The oncology is expected to account for the largest share during the forecast period in application market

In 2025, the oncology segment is expected to dominate the market with the largest market share with 49.4% due to the growing prevalence of cancer worldwide and advanced nuclear imaging technology, notably PET and SPECT have seen significant expansion owing to their unmatched capability to thoroughly examine the molecular traits specific to cancer.

Nuclear Imaging Devices Market Regional Analysis

“U.S. Holds the Largest Share in the Nuclear Imaging Devices Market”

• The U.S. holds a significant share of the North American nuclear imaging devices market with 34.3%. This dominance is attributed to advanced healthcare infrastructure, high healthcare expenditure, and a substantial patient base requiring diagnostic imaging
• The U.S. is at the forefront of adopting cutting-edge nuclear imaging technologies, including PET/CT and SPECT/CT systems. This early adoption enhances diagnostic accuracy and treatment planning, further solidifying its market leadership
• Major companies such as Siemens, Philips, and Canon have a strong presence in the U.S., driving innovation and market growth through continuous product development and strategic partnerships
• Favorable regulatory policies and reimbursement frameworks in the U.S. healthcare system encourage the adoption of advanced imaging technologies, facilitating market expansion

“Canada is Projected to Register the Highest CAGR in the Nuclear Imaging Devices Market”

• Canada is experiencing the fastest growth in the North American nuclear imaging devices market, driven by increasing healthcare investments and technological advancements
• Canadian government initiatives aimed at enhancing healthcare infrastructure and providing better access to diagnostic services contribute to the rising demand for nuclear imaging devices
• The growing elderly population in Canada leads to a higher incidence of chronic diseases, necessitating advanced diagnostic imaging solutions such as nuclear imaging
• Improvements in Canada's healthcare system, including the adoption of state-of-the-art medical technologies, support the expansion of nuclear imaging services
• The combination of technological advancements, supportive policies, and demographic trends positions Canada as a rapidly growing market for nuclear imaging devices in North America

Nuclear Imaging Devices Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

The Major Market Leaders Operating in the Market Are:

• DIGIRAD CORPORATION (U.S.)
• Mediso Ltd. (U.S.)
• CMR Naviscan. (U.S.)
• Absolute Imaging Inc. (Canada)
• BCL X-Ray Canada Inc. (Canada)
• TTG Imaging Solutions, LLC (U.S.)
• Mirion Technologies (Capintec), Inc. (U.S.)
• LANDAUER (U.S.)
• Lucerno Dynamics, LLC. (U.S.)
• Incom, Inc. (US), Siemens (U.S.)

Latest Developments in North America Nuclear Imaging Devices Market

• In July 2024, The Shanghai United Imaging Healthcare Co., LTD announced the installation of the first PET/CT scanner in Mexico, located at the Instituto Nacional de Pediatría
• In June 2024, GE Healthcare enhanced its technology portfolio with the introduction of the MINItrace Magni, a compact cyclotron designed for reliable in-house production of commercial PET tracers and radiometals; the Omni Legend 21 cm, a performance-driven PET/CT system aimed at addressing the increasing demands of healthcare systems across various care areas; and Clarify DL, a new deep learning reconstruction technology that provides clear, accurate, and seamless imaging
• In May 2023, Koninklijke Philips N.V., Elekta, and Mercurius Health announced a 3-year agreement, under which Philips and Elekta installed the diagnostic & therapeutic oncology equipment and aligned informatics solutions at Mercurius Health’s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany
• In May 2024, Blue Earth Diagnostics, a Bracco company, has inked a non-exclusive data-sharing pact with Siemens Healthineers. The agreement covers the sharing of anonymized clinical data and images of POSLUMA® (previously 18F-rhPSMA-7.3) injection from Blue Earth Diagnostics' Phase 3 LIGHTHOUSE trial, focusing on newly diagnosed prostate cancer
• In March 2023, Positron Corporation signed a Clinical Study/Research Agreement with the Ochsner Clinic Foundation and Dr. Bober, Director of Molecular Imaging and Nuclear Cardiology at Ochsner Health. Under the agreement, the company and the organizations would carry out clinical studies of its new PET-CT imaging device, the Affinity PET-CT 4D     

SKU-1436